Clinical research gives patients hope that new cancer therapies will be life-saving. Phase II and III clinical trials test in patients the effectiveness of experimental drugs which have been developed through years of earlier research progress.
These patient studies are the best—if not only—way to advance medicine. They evaluate results, inspire confidence and validate new ways of treatment.
As essential as they are, clinical trials can also be lengthy, costly and—among some people—thought to entail too much risk. But the National Foundation for Cancer Research has established and supported new platforms to move beyond these negative characteristics—real and perceived—of clinical research.